Clinical Guides
Type 1 Diabetes Mellitus
An India-contextualised, clinically focused guide to recognising type 1 diabetes, prescribing insulin safely, using glucose technology, preventing hypoglycaemia and DKA, and planning lifelong complication and pregnancy care.
MedNext Academy | 12 min read
Type 1 Diabetes Mellitus
An India-contextualised, clinically focused guide to recognising type 1 diabetes, prescribing insulin safely, using glucose technology, preventing hypoglycaemia and DKA, and planning lifelong complication and pregnancy care.
Summary
Type 1 diabetes (T1D) is diabetes caused by severe or absolute insulin deficiency, most often from immune-mediated beta-cell destruction. It can begin in childhood, adolescence or adulthood; age, body mass index and family history do not reliably classify it. People require insulin from diagnosis and throughout life, although a short partial-remission phase may occur. Without insulin, lipolysis and ketogenesis can rapidly produce diabetic ketoacidosis (DKA).
Safe care combines basal insulin, meal-related insulin, glucose monitoring, nutrition and physical-activity education, hypoglycaemia prevention, sick-day rules, psychosocial support and screening for associated autoimmune disease and complications. Continuous glucose monitoring (CGM), pumps and automated insulin delivery can improve safety for selected people, but access, training, calibration, skin care, alarm fatigue and uninterrupted backup insulin matter. Human insulin remains clinically useful where cost or supply limits analogues.
This is educational material for supervised learning in India, not an individual dose prescription. A person with vomiting, ketones, deep breathing, dehydration, confusion or severe hypoglycaemia needs urgent medical assessment. Never stop basal insulin during illness without a specialist plan. Confirm every formulation, concentration, device and dose; local protocols and current product information govern prescribing.
How Common Is It?
T1D is less common than type 2 diabetes, but its burden is substantial because insulin, monitoring and education are lifelong. International incidence varies by ancestry, age, latitude, ascertainment and case definition. India does not have one complete national registry that can support a precise contemporary incidence or prevalence claim for every state. Hospital datasets over-represent severe presentations and people who reach specialist care, while community surveys may miss children and adults with limited access. Avoid presenting a local clinic denominator as a national estimate.
T1D can present at any age. Adult-onset autoimmune diabetes may be mistaken for type 2 diabetes, especially when ketosis has not yet occurred. Conversely, ketosis-prone and monogenic diabetes can be mislabelled T1D. Services should monitor time from symptom onset to diagnosis, DKA at presentation, severe hypoglycaemia, supply interruption, HbA1c trajectory, access to CGM and screening completion rather than relying on prevalence alone.
In India, cost of insulin, strips, ketone testing, travel, refrigeration and specialist review shapes outcomes. Adolescence, food insecurity, mental-health problems, stigma, school or work constraints and family conflict can make a technically correct regimen unsafe in practice. A non-judgmental assessment should identify these barriers and connect the person with social, dietary, psychological and diabetes-team support.
Risk Factors
T1D susceptibility reflects genetic risk and environmental or immune triggers, but no single exposure proves causation. A first-degree relative with T1D or another autoimmune disease increases probability without making diagnosis clinical. Coeliac disease, autoimmune thyroid disease, pernicious anaemia and Addison disease may coexist. Immune-checkpoint inhibitors can cause abrupt insulin-deficient diabetes. Pancreatic disease, surgery, cystic-fibrosis-related diabetes and selected monogenic syndromes require a different classification and may alter associated screening.
Risk of DKA rises with delayed diagnosis, infection, insulin omission, pump or infusion-set failure, spoiled insulin, fasting, vomiting, pregnancy, steroid exposure and inadequate sick-day education. SGLT2 inhibitors are not routine T1D therapy in India and can precipitate euglycaemic DKA; any use should trigger specialist risk review. Severe hypoglycaemia is more likely with impaired awareness, kidney disease, irregular meals, alcohol, unplanned exercise, older age, cognitive or visual impairment, intensive insulin and lack of glucagon or a trained companion.
Social risks are clinical risks: interrupted electricity, long journeys, heat, stock-outs, unaffordable strips, unsafe needle reuse, language barriers and fear of disclosure at school or work. Ask what insulin is actually available, where it is stored, who can administer it, and whether the family can respond to a low glucose or ketone result. Do not describe these barriers as poor compliance.
Diagnosis
History
Ask about polyuria, polydipsia, nocturia, weight loss, fatigue, blurred vision, infections, abdominal pain, nausea, vomiting, breathing change and altered behaviour. Establish onset, recent illness, medicines, steroid or immune therapy, dietary restriction, pregnancy possibility and family or autoimmune history. Document every insulin product, concentration, dose, timing, last dose, storage and delivery device. Ask about CGM or meter readings, ketones, hypoglycaemia, glucagon access, injection technique, school or workplace needs and affordability.
Examination
Assess airway, breathing, circulation, hydration, temperature, mental state and perfusion before treating hyperglycaemia as routine. Record weight, growth or pubertal stage in children and adolescents, blood pressure and injection sites for lipohypertrophy or infection. Look for thyroid enlargement, vitiligo, pallor, dehydration, Kussmaul breathing, abdominal tenderness and signs of sepsis. Examine feet and vision when stable. A normal appearance does not exclude ketosis; repeat observations if symptoms evolve.
Investigations
Confirm diabetes with plasma glucose or HbA1c using accepted criteria, but do not delay emergency treatment for classification. In an unwell person obtain blood beta-hydroxybutyrate where available, venous blood gas, electrolytes, renal function, glucose, urine output and osmolality when indicated. Islet autoantibodies support autoimmune classification; C-peptide is interpreted with concurrent glucose and after the acute state, not as a reason to withhold insulin. Check thyroid function and coeliac screening according to local protocol. HbA1c, lipids, urine albumin-creatinine ratio, retinal assessment and foot examination form later baseline care.
Differential Diagnosis
Type 2 diabetes can occur in a young person with obesity or family history, but these features do not exclude T1D. Ketosis-prone diabetes may present with DKA and later show recoverable beta-cell function; classification requires follow-up, not a trial of stopping insulin. Monogenic diabetes, pancreatic diabetes, cystic-fibrosis-related diabetes and endocrine disorders deserve consideration when the phenotype, family pattern, antibody results or C-peptide is atypical. Stress hyperglycaemia during infection should be reassessed after recovery.
DKA, HHS, starvation ketosis, alcoholic ketoacidosis, lactic acidosis and toxic ingestion can overlap. Euglycaemic DKA is important during pregnancy, fasting, reduced carbohydrate intake or SGLT2 exposure. Abdominal pain and vomiting may be DKA, but appendicitis, pancreatitis, gastroenteritis, pregnancy-related disease and sepsis must not be missed. A low glucose may result from excessive basal or meal insulin, renal failure, alcohol, exercise, adrenal insufficiency or a dosing error.
Apparent glycaemic variability may reflect inaccurate meter technique, sensor compression, missed doses, injection into lipohypertrophy, device failure, altered insulin storage, carbohydrate mismatch or changing insulin needs during puberty, illness, menstruation and pregnancy. Confirm the pattern before escalating. Do not infer deliberate omission from unexplained readings; ask about access, fear, distress, eating disorder and mental health.
Management
Start insulin promptly when T1D is diagnosed. Most people need basal insulin plus rapid-acting or regular insulin matched to meals, with correction rules and education on carbohydrate estimation. Regimen choice depends on age, work or school, meal pattern, kidney function, hypoglycaemia risk, dexterity, vision, cost and reliable supply. Pumps and automated delivery may improve time in range and reduce burden for selected users, but pump interruption can cause ketosis within hours because no long-acting insulin is present; every user needs backup injections, batteries, infusion sets and a written failure plan.
CGM can show trends, alarms and time below range, but confirm unexpected readings with a meter when symptoms and sensor disagree, during rapid change or before making a high-risk decision if the device requires it. Teach calibration and skin care according to the product. Nutrition education should include carbohydrate, fibre, illness, alcohol and culturally familiar meals, not rigid prohibition. Exercise needs planned carbohydrate and/or insulin adjustment with delayed nocturnal hypoglycaemia discussed.
Give a written hypoglycaemia plan: treat an alert or conscious low with fast-acting carbohydrate, recheck, repeat if needed, and use prescribed glucagon for severe low glucose when the person cannot safely swallow. Do not give oral food to an unconscious person. Screen for distress, depression, disordered eating, bullying and diabetes distress. Review goals collaboratively; an HbA1c target is not safe if achieved through recurrent severe lows.
Prescribing Information
Write the exact insulin name, concentration, device, route, dose in full units and timing. Never write U or IU ambiguously and never convert a concentrated product using an unmatched syringe. Verify pen, cartridge, vial and needle compatibility, injection depth, priming and dwell time. Rotate sites and avoid lipohypertrophy. Do not share pens. Basal insulin should usually continue during fasting or illness; a person with T1D needs an agreed sick-day adjustment, not internet-derived correction formulas.
Human regular and NPH insulin remain reasonable, affordable choices when the person can manage their timing and monitoring. Rapid-acting and long-acting analogues may reduce some hypoglycaemia or timing burdens, but cost and continuous availability matter. Protect insulin from freezing, heat and direct sun; unopened stock generally follows the labelled cold chain, while in-use storage duration is product-specific. In hot climates use an approved insulated method without direct ice contact and replace stock if temperature integrity is doubtful.
Review kidney and liver function, puberty, pregnancy, steroid use, exercise, alcohol, fasting, eating pattern and severe lows before adjustment. Document strips, ketone testing, needles, lancets, glucagon, sharps disposal, sick-day contacts and access to emergency insulin. Pump or CGM prescriptions require training, insertion-site review, alarm education and a backup injection plan. Product selection and titration remain specialist decisions when severe hypoglycaemia, recurrent DKA, pregnancy, advanced kidney disease or uncertain classification is present.
When to Refer
Same-day emergency care is required for suspected DKA or HHS, persistent vomiting, moderate or high blood ketones, deep breathing, dehydration, shock, confusion, inability to keep fluids down or severe hypoglycaemia requiring another person's help. A new presentation that may be T1D needs diabetes-team involvement even if the person is not acidotic. A person who will run out of insulin today needs an urgent supply solution, not a routine appointment.
Refer to an endocrinology or multidisciplinary diabetes service when diagnosis is uncertain, glycaemia is unstable despite verified technique, severe or nocturnal hypoglycaemia recurs, awareness is impaired, DKA repeats, pump or CGM is being considered, kidney disease progresses, eating disorder or diabetes distress is suspected, or pregnancy is planned or confirmed. Paediatric and adolescent care should include school planning and family transition support.
Urgent eye, foot, renal, cardiovascular, thyroid, coeliac, dietary or psychological referral follows findings. Before transfer provide current insulin and concentration, recent glucose and ketone data, vital signs, renal function, pregnancy status, suspected trigger and treatment already given. Referral does not replace primary-care responsibility for uninterrupted prescriptions, supplies, education and follow-up.
Red Flags
DKA warning signs include vomiting, abdominal pain, marked thirst, polyuria followed by reduced urine, dehydration, fruity breath, deep or rapid breathing, rising ketones, drowsiness and confusion. Glucose may be only modestly raised in euglycaemic DKA. Do not stop basal insulin or repeatedly self-correct while delaying assessment. Severe hypoglycaemia includes seizure, unconsciousness, inability to swallow, marked confusion or a low requiring assistance; place the person safely, use glucagon if available and seek emergency help.
Pump users need immediate action for unexplained hyperglycaemia, a dislodged or occluded set, empty reservoir, battery or alarm failure, because rapid-acting insulin interruption can cause DKA. Check capillary glucose and ketones, inspect the system, use the prescribed backup injection and escalate if ketones or symptoms rise. CGM compression lows, sensor failure and delayed readings can mislead; symptoms and a meter result matter.
Pregnancy, postpartum change, acute kidney injury, prolonged fasting, severe infection, steroid initiation and transition from intravenous to subcutaneous insulin are high-risk periods. Recurrent lows, falls, driving events, nocturnal sweating or impaired awareness require regimen review. Any uncertain insulin concentration, frozen or overheated stock, millilitre-only instruction, needle mismatch, injection-site abscess or sudden visual change is a medication or complication red flag.
Indian Clinical Context
Indian T1D care ranges from tertiary centres with pumps, CGM and ketone meters to clinics where human insulin and intermittent capillary testing are the dependable option. A safe plan must be achievable with the person's money, travel, electricity, food pattern and language. Provide local-language written and demonstration-based teaching, use return-demonstration, and involve family or school with consent. Do not frame technology as a prerequisite for good care, but do not understate its potential value for recurrent severe hypoglycaemia or difficult access.
Plan for heat, transport and power interruption. Follow the product leaflet for cold-chain and in-use life; never freeze insulin or place it directly against ice. Ensure a spare vial or pen, needles, meter, strips, ketone strategy and glucagon where appropriate. Discuss fasting during religious observance with the diabetes team in advance. A community worker can reinforce appointments and danger signs but cannot independently alter insulin.
Indian clinicians should consider tuberculosis, dengue, malaria, enteric infection, urinary or skin infection according to presentation and local surveillance; do not order indiscriminate panels or infer infection from leukocytosis alone. Antimicrobials and steroids can change insulin need. Link care with NP-NCD services, school health, social support and affordable procurement. Screen for autoimmune thyroid and coeliac disease, renal and retinal complications, neuropathy and foot risk according to current Indian and international standards.
NMC Competency Mapping
NMC undergraduate medicine competencies on diabetes integrate recognition, diagnosis, chronic management, complications, emergencies and rational pharmacotherapy. The learner should explain absolute insulin deficiency, ketogenesis, osmotic diuresis and the distinction between DKA and HHS. They should recognise that T1D may occur at any age, that adult phenotype can be misleading, and that insulin is replacement therapy rather than a consequence of personal failure. Exact competency codes should be checked against the official NMC CBME 2024 compendium and the institution's current mapping.
A supervised learner should take a non-judgmental history of symptoms, insulin access, storage, delivery, glucose trends, ketones, hypoglycaemia, diet, exercise, illness, pregnancy and psychosocial safety. They should examine hydration and injection sites, interpret glucose, ketones, pH, bicarbonate, potassium, HbA1c and selected classification tests, and state when emergency escalation is needed. They should demonstrate hypoglycaemia treatment, sick-day counselling, teach-back and safe handover.
Independent initiation or alteration of complex basal-bolus, pump, automated delivery, pregnancy or DKA treatment is beyond an unsupervised student's role. Assessment should reward explicit safety boundaries: basal insulin continuity, ketone testing during illness, no oral intake during unconsciousness, product-specific storage, and early referral for recurrent DKA or severe hypoglycaemia. Competency demonstrates supervised clinical reasoning; it does not confer prescribing authority.
Key Exam Pearls for NEET PG
T1D is usually autoimmune beta-cell destruction with absolute insulin deficiency, but it can present at any age and autoantibodies may be negative. DKA requires diabetes or significant hyperglycaemia, ketonaemia and metabolic acidosis; euglycaemic DKA is associated with pregnancy, fasting and SGLT2 inhibitors. Total-body potassium is depleted even when serum potassium initially appears normal or high. Insulin must not be stopped simply because a patient is not eating.
Basal insulin covers background requirements; prandial insulin covers meals. A pump uses rapid-acting insulin only, so interruption can cause ketosis quickly and requires backup injection. CGM trend arrows and alarms assist but do not override symptoms, meter confirmation or clinical assessment. Treat conscious hypoglycaemia with fast carbohydrate; never place food in an unconscious person's mouth. Glucagon is for severe hypoglycaemia when prescribed and available.
High-yield safety distinctions include injection into lipohypertrophy causing erratic absorption, kidney failure lowering insulin clearance, exercise causing immediate or delayed lows, and pregnancy changing insulin needs. Screen for thyroid and coeliac disease and for retinal, renal, foot and neuropathic complications. Human insulin can be an appropriate lower-cost option. Technology, analogue insulin and a low HbA1c are not automatically superior if supply, training or safety is absent.
Frequently Asked Questions
Can an adult with a normal body weight still have type 1 diabetes?
Yes. Type 1 diabetes can start at any age and body size. Adult-onset autoimmune diabetes may initially resemble type 2 diabetes, while ketosis-prone or monogenic diabetes can look different again. Symptoms, ketones, course, antibodies and C-peptide interpreted with glucose support classification. Do not delay insulin when deficiency or DKA is clinically likely.
Should basal insulin be stopped when a person with type 1 diabetes is vomiting or not eating?
Usually no. Insulin deficiency can worsen rapidly during illness even when food intake falls. Follow the person's written sick-day plan, check glucose and ketones, maintain fluids and carbohydrate as tolerated, and seek urgent care for rising ketones, persistent vomiting, deep breathing, dehydration or confusion. Dose changes require clinical guidance; do not use a generic internet formula.
Are continuous glucose monitors and pumps essential for safe type 1 diabetes care?
They can improve monitoring and reduce some hypoglycaemia burden for selected people, but they are not prerequisites for effective care. Human insulin and capillary monitoring can be appropriate when education, supply and follow-up are reliable. Technology requires training, skin and device review, alarm interpretation, access to consumables and a backup injection plan. A pump interruption is an emergency risk because it contains no long-acting insulin.
What should a family do during severe hypoglycaemia?
If the person is unconscious, having a seizure or unable to swallow, place them safely on their side, do not give food or drink by mouth, use prescribed glucagon if available and call emergency services. Once awake and able to swallow, give fast-acting carbohydrate and recheck glucose as instructed. Any episode needing assistance warrants diabetes-team review of insulin, kidney function, alcohol, exercise, awareness, driving and access to glucagon.
Inside MedNext for this topic
- 411 MedNext-authored chapters
- 80,000+ MCQ bank
- 15 study modes
- a growing library of visual revision sheets
Study modes
- Notes
- MCQ
- Audio
- Video
- Visual
- 3D Anatomy
- Trace
- Flashcards
- Mnemonics
- Image Bank
- Clinical
- Microscopy
- Audio QBank
- Cadaver
- Book Match
Continue reading
Clinical GuidesAll Clinical Guides
Browse all clinical management guides for Indian medical practice.
Test your knowledge
Attempt structured MCQs on this topic to consolidate your understanding and connect the guide to exam-focused practice.
Try MCQs on this topic